TY  - GEN
AU  - Zook,Phillip
AU  - Pathak,Harsh B
AU  - Belinsky,Martin G
AU  - Gersz,Lawrence
AU  - Devarajan,Karthik
AU  - Zhou,Yan
AU  - Godwin,Andrew K
AU  - von Mehren,Margaret
AU  - Rink,Lori
TI  - Combination of Imatinib Mesylate and AKT Inhibitor Provides Synergistic Effects in Preclinical Study of Gastrointestinal Stromal Tumor
SN  - 1557-3265
PY  - 2018///0202
KW  - Animals
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Cell Line, Tumor
KW  - Cell Survival
KW  - drug effects
KW  - Disease Models, Animal
KW  - Dose-Response Relationship, Drug
KW  - Drug Evaluation, Preclinical
KW  - Drug Synergism
KW  - Gastrointestinal Stromal Tumors
KW  - drug therapy
KW  - Gene Expression Profiling
KW  - Heterocyclic Compounds, 3-Ring
KW  - Humans
KW  - Imatinib Mesylate
KW  - Mice
KW  - Protein Kinase Inhibitors
KW  - Proto-Oncogene Proteins c-kit
KW  - antagonists & inhibitors
KW  - Signal Transduction
KW  - Survival Analysis
KW  - Tumor Burden
KW  - Exome Sequencing
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1158/1078-0432.CCR-16-0529
ER  -